U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry RACEMIC
Molecular Formula C22H35NO5
Molecular Weight 393.517
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DIVABUTEROL

SMILES

CC(C)(C)NCC(O)C1=CC(OC(=O)C(C)(C)C)=CC(OC(=O)C(C)(C)C)=C1

InChI

InChIKey=VJJOKWOJJZKXNV-UHFFFAOYSA-N
InChI=1S/C22H35NO5/c1-20(2,3)18(25)27-15-10-14(17(24)13-23-22(7,8)9)11-16(12-15)28-19(26)21(4,5)6/h10-12,17,23-24H,13H2,1-9H3

HIDE SMILES / InChI

Molecular Formula C22H35NO5
Molecular Weight 393.517
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description

Divabuterol or terbutaline dipivalate is a prodrug of terbutaline. The half-life of terbutaline dipivalate in human plasma is less than five minutes. Therapeutically, most forms of terbutaline can be used as bronchodilators in antiasthmatic treatment, as smooth muscle relaxants to treat premature labour (uterine relaxant) and for a number of other indications.

Approval Year

PubMed

Patents

Substance Class Chemical
Record UNII
BVG9H4U2ZB
Record Status Validated (UNII)
Record Version